MedTrace Logo

Islet Function and Clinical Analyses of Transplant Recipients

NCT00870831 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 8

Last updated 2014-12-10

No results posted yet for this study

Summary

To follow the patterns and natural history of Islet Transplant recipients (the ones that were involved in the Modified Edmonton Protocol) using oral glucose to check sugar levels as well as insulin and C-peptide over the course of 5 years

Conditions

  • Type One Diabetes Mellitus

Interventions

OTHER

OGTT (Oral Glucose Tolerance Test)

Subjects would consume 75grams of sugar (Dextrose, 10 oz) and blood samples taken at specified time points to measure glucose, insulin and C-peptide

Sponsors & Collaborators

  • Washington University School of Medicine

    lead OTHER

Principal Investigators

  • Kenneth S Polonsky, MD · Washington University School of Medicine

  • Daniel C Brennan, MD · Washington University School of Medicine

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2000-10-31
Primary Completion
2010-03-31
Completion
2010-03-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00870831 on ClinicalTrials.gov